Long Alison S 4
4 · Kaleido Biosciences, Inc. · Filed Dec 16, 2021
Insider Transaction Report
Form 4
Long Alison S
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-15+300,000→ 300,000 totalExercise: $3.08Exp: 2031-12-14→ Common Stock (300,000 underlying) - Award
Restricted Stock Units
2021-12-15+24,350→ 24,350 total→ Common Stock (24,350 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on December 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F3]The restricted stock units shall vest 100% on December 15, 2023.